| 15:40 - 16:40 | Thematic Session: Organ utilization - do we need to challenge each other to do better? |
250.1 |
The promise of equity in a deceased donor allocation system Chris Callaghan, United Kingdom |
250.2 |
Strategies to improve non-utilisation rates of deceased donors Sumit Mohan, United States |
250.3 |
Reducing the risk of donor transmitted disease Beatriz Dominguez-Gil, Spain |
| 15:40 - 16:40 | Thematic Session: Genetics in precision medicine |
251.1 |
Genetics for precision medicine in transplantation Shane T Grey, Australia |
251.2 |
Biopsy transcriptomics for diagnosis and research Jasper Callemeyn, Belgium |
251.3 |
Identifying operational tolerance Megan Sykes, United States |
| 15:40 - 16:40 | Thematic Session: Promises of big data and AI - facts or fiction? |
252.1 |
Machine learning model for outcome prediction Nancy Kwan Man, Hong Kong |
252.2 |
Application of AI in transplant pathology Weijia Zhang, United States |
252.3 |
Developing transplant registries in LMIC and MIC Adisorn Lumpaopong, Thailand |
| 15:40 - 16:40 | Thematic Session: Pancreas and islet |
253.1 |
Beta cell replacement (whole pancreas, islet and cell transplantation) within the treatment landscape of type 1 diabetes Braulio Alejandro Marfil-Garza, Mexico |
253.2 |
Deciphering the immunological enigma of allo-beta cell transplantation: Addressing unresolved questions and embracing the frontiers of knowledge Lorenzo Piemonti, Italy |
253.3 |
Avoiding the need for immunosuppression in islet transplantation Xiaomeng Hu, United States |
| 15:40 - 16:40 | Thematic Session: Life participation and living well after transplantation |
255.1 |
Living well after transplantation Bill Wang, Hong Kong |
255.2 |
Work, life, and sex after transplantation Louise Lerminiaux, Costa Rica |
255.3 |
Prehabilitation into transplant and beyond Marieke Vandecruys, Belgium |
| 15:40 - 16:40 | Thematic Session: Uterus-transplantation: Where are we now |
256.1 |
10 years after the first successful uterus transplant: How will the teenage years look? Mats Brannstrom, Sweden |
256.2 |
Ethical guardrails in uterus transplantation Anji Wall, United States |
| 256.3 |
Uterus-specific aspects of alloimmunity and immunosuppression Jana Ekberg, Sweden |
| 15:40 - 16:40 | Thematic Session: Clinical trials design and end-points in transplantation |
257.1 |
Innovative trial design in transplantation Andrea Viecelli, Australia |
257.2 |
The Parsons Model - ethical implications of research involving those determined dead by neurological criteria Jayme Locke, United States |
257.3 |
Trials in immunosuppression/Long term in kidney transplantation Roslyn B. Mannon, United States |
| 16:50 - 18:30 | Abstract Session: Lung Transplantation |
| 263.10 |
Exploring acceptability of lung uDCD among clinical and community stakeholders in New York City Jingzhi Xu, United States |
| 08:00 - 09:15 | Abstract Session: Liver complications & techniques |
301.2 |
A decision-making approach based on computer modelling of blood flow in hepatic vessels Ekaterina Yu Anosova, Russian Federation |
| 13:40 - 15:10 | Abstract Session: Kidney Living Donor Transplant 2 |
| 341.2 |
A novel equation to predict improvement in creatinine in ESRD patients following a living donor kidney transplant Ashraf El-Hinnawi, United States |
| 13:40 - 15:10 | Abstract Session: Patient centered care in Tx |
| 347.3 |
A qualitative exploration of family resiliency in pediatric living-related liver donation Annette S Nasr, United States |
| 15:40 - 16:40 | Thematic Session: Organ perfusion and preservation |
350.1 |
Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation Emily R. Thompson, United Kingdom |
350.2 |
Ex-situ machine perfusion (heart, liver, kidney) (standard, oxygenated, hypothermic, normothermic) Gabriel Oniscu, Sweden |
350.3 |
Cryopreservation Erik Finger, United States |
| 15:40 - 16:40 | Thematic Session: Dealing with post-transplant complications |
351.1 |
De novo malignancy post-transplant Naoka Murakami, United States |
351.2 |
What's new in vaccines? Andrew Karaba, United States |
351.3 |
Managing post-transplant metabolic disease Wai Lim, Australia |
| 15:40 - 16:40 | Thematic Session: Kidney transplant surgery |
352.1 |
The best way to procure live donor kidneys: Robotic vs. laparoscopic donor nephrectomy Chandra Bhati, United States |
352.2 |
Robotic renal transplantation: State of the art Sangil Min, Korea |
352.3 |
Robotic renal transplantation: A niche approach for selected patients or the future surgical approach for all? Timucin Taner, United States |
| 15:40 - 16:40 | Thematic Session: Advances in antibody assessment |
353.1 |
ABO antibodies - future perspectives Lori J. West, Canada |
353.2 |
Advances in AB detection: From Luminex to Eplets and more Cynthia Kramer, Netherlands |
353.3 |
Applying AB detection techniques in real life Anne Halpin, Canada |
| 15:40 - 16:40 | Thematic Session: Reproductive care - General |
355.1 |
Gestational outcomes for transplant recipients: A focus on fetal health Margriet FC de Jong, Netherlands |
355.2 |
Impact of pregnancy on graft function in kidney Tx Marleen van Buren, Netherlands |
355.3 |
Reproductive planning - why & how Shilpanjali Jesudason, Australia |
| 15:40 - 16:40 | Thematic Session: Equity and access to transplantation |
356.1 |
Risks to equity in organ allocation introduced by AI Mamatha Bhat, Canada |
356.2 |
Disparity in access to solid organ transplantation Lungiswa LS Mtingi-Nkonzombi, South Africa |
356.3 |
Sex and gender disparities in transplantation access Bethany Foster, Canada |
| 15:40 - 16:40 | Thematic Session: Cellular therapies |
357.1 |
Dendritic cells - insights from clinical trials Angus W Thomson, United States |
357.2 |
CAR-Treg optimization Mohsen Khosravi-Maharlooei, United States |
357.3 |
Adoptive t-cell therapy for infections Patrizia Comoli, Italy |
| 08:00 - 09:15 | Abstract Session: Lung translational |
| 401.5 |
Lung uDCD protocol refinement in partnership with clinical, regulatory, and community stakeholders in New York City Stephen P Wall, United States |
| 08:00 - 09:15 | Abstract Session: Ethics in organ donation |
| 405.8 |
Sociocultural experiences and meanings of kidney transplant in Mexican patients: A qualitative study Carolina Espinosa-Escobar, Mexico |
| 09:30 - 10:30 | Abstract Session: Liver quality & live donor |
| 413.1 |
Factors influencing the use of non-ideal deceased donor livers for transplantation: a qualitative study of U.S. transplant center leaders David C Cron, United States |
| 15:25 - 16:25 | Thematic Session: Surfing the big data wave |
450.1 |
Patient centred outcomes measures Nicole J Scholes-Robertson, Australia |
450.2 |
Genomics strategies to redefine histocompatibility and risk stratification Sophie Limou, France |
450.3 |
Is AI better than human in predicting post-transplant outcomes? Carmen Lefaucheur, France |
| 15:25 - 16:25 | Thematic Session: Infection complications in transplantation |
451.1 |
Climate change and Infection - how it affects transplantation Ilan Schwartz, United States |
451.2 |
COVID-19 infections and impact on transplant outcomes in the Middle-East Sibel Gokcay Bek, Turkey |
451.3 |
Recurrent UTI in solid organ transplant recipient Deepali Kumar, Canada |
| 15:25 - 16:25 | Thematic Session: Minimally invasive recipient surgery: The future is here (Liver) |
452.1 |
How far can we expand the indication of Robot-assisted LDLT? Dieter C. Broering, Saudi Arabia |
452.2 |
Which is better for graft extraction/insertion? Upper midline incision vs, Pfannenstiel incision Mohamed Rela, India |
452.3 |
Which is better for graft explant and/or graft implantation? Laparoscopic vs. Robot Assisted Kwang-Woong Lee, Korea |
| 15:25 - 16:25 | Thematic Session: Regenerative medicine |
454.1 |
Regenerative medicine in cardiology James Chong, Australia |
454.2 |
Overcoming senescence to improve transplant outcome Anette Melk, Germany |
454.3 |
Tissue engineering and organ fabrication Rui L. Reis, Portugal |
| 15:25 - 16:25 | Thematic Session: Patient-centered care |
455.1 |
Ready-Steady-Go/A blueprint for health care transition in Europe? Arvind Nagra, United Kingdom |
455.2 |
The therapy in wellness, movement and community Liz Schick, Switzerland |
455.3 |
Shared decision making in post-transplant care Gerardo Reyna, Spain |
| 15:25 - 16:25 | Thematic Session: Xenotransplantation’s regulatory road to the clinic |
456.1 |
History of Xenotransplantation and moving to clinical practice Wayne Hawthorne, Australia |
456.2 |
WHO leadership in developing global strategies for xenotransplantation Efstratios (Stratos) Chatzixiros, Switzerland |
456.3 |
Moving forward to ensure continuing registration of clinical Xenotransplantation Leo Hans Buhler, Switzerland |
|
Questions from audience Discussion Period, Turkey |
| 15:25 - 16:25 | Thematic Session: Normothermic regional perfusion (A-NRP and TA-NRP) |
457.1 |
Implications of NRP and especially TA-NRP for death determination Dale Gardiner, United Kingdom |
|
457.2 |
The surgical approach - the US perspective Anji Wall, United States |
457.3 |
The surgical approach - the Spanish perspective Alicia Pérez, Spain |